Congenital isolated central hypothyroidism: Novel mutations and their functional implications

Area of Science:

• Endocrinology
• Genetics
• Neonatal Medicine

Background:

• Congenital hypothyroidism (CH) is the most common endocrine disorder in newborns, affecting 1 in 3000-4000 live births.
• Neonatal screening programs, like the one in the Netherlands using thyroxine (T4) heel prick tests, detect both primary and central CH.
• Recent decades have seen the identification of novel genetic causes for isolated congenital central hypothyroidism (ICCH).

Purpose of the Study:

• To review recent genetic discoveries in isolated congenital central hypothyroidism.
• To highlight the expanding understanding of the hypothalamus-pituitary-thyroid axis regulation.
• To emphasize the impact of these findings on improving diagnosis and treatment strategies for CH.

Main Methods:

• Review of recent scientific literature identifying genetic mutations associated with congenital central hypothyroidism.
• Analysis of identified genes, including immunoglobulin superfamily member 1 (IGSF1), transducin β-like 1X (TBL1X), and insulin receptor substrate 4 (IRS4).
• Discussion of the functional roles of these genes in hypothalamic regulation of the thyroid axis.

Main Results:

• Mutations in IGSF1 are the most common genetic cause of isolated central hypothyroidism.
• TBL1X gene mutations are linked to central hypothyroidism and sensorineural hearing loss.
• IRS4 gene mutations have been identified in familial isolated central hypothyroidism cases.

Conclusions:

• Recent genetic findings have significantly advanced the understanding of isolated central hypothyroidism.
• The identified genes (IGSF1, TBL1X, IRS4) play crucial roles in the hypothalamus-pituitary-thyroid axis.
• This knowledge is vital for improving diagnostic accuracy and therapeutic interventions for congenital hypothyroidism.